S 1157
· 119th Congress
· Health
Women and Lung Cancer Research and Preventive Services Act of 2025
Sponsor
Latest action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 308.
Action timeline
Every recorded action on this bill, newest first. Stage badges color-code the legislative path.
Jan 28, 2026
committee
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
Health, Education, Labor, and Pensions Committee
Jan 28, 2026
other
Placed on Senate Legislative Calendar under General Orders. Calendar No. 308.
Jan 15, 2026
committee
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Health, Education, Labor, and Pensions Committee
Mar 26, 2025
introduced
Introduced in Senate
Mar 26, 2025
introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee
Text versions
Each stage of the bill — official text published by GPO. Click any format to read on congress.gov / govinfo.
Changelog
ⓘ
How a bill moves through Congress. Each stage produces a new official text. The diff between them shows what changed at that step.
ih / is — Introduced in House / Senate. First filed version.rfh / rfs — Referred to a committee for review.rh / rs — Reported back by the committee to the floor (often with amendments — this is where most language changes happen).pcs / pch — Placed on Calendar for floor consideration.eh / es — Engrossed. Passed by the originating chamber. Text is now what was actually voted on.rdh / rds — Received by the other chamber.eah / eas — Engrossed Amendment. The other chamber passed an amended version.ath / ats — Agreed to. Both chambers settled on the same text.enr — Enrolled. Final reconciled text, sent to the President.pl — Public Law. Signed by the President. It's now law.pp — Public Print. Official printing post-enactment.
Most bills die before eh/es. Going from pcs → enr is the full path through both chambers.
ⓘ
How a bill moves through Congress. Each stage produces a new official text. The diff between them shows what changed at that step.
ih/is— Introduced in House / Senate. First filed version.rfh/rfs— Referred to a committee for review.rh/rs— Reported back by the committee to the floor (often with amendments — this is where most language changes happen).pcs/pch— Placed on Calendar for floor consideration.eh/es— Engrossed. Passed by the originating chamber. Text is now what was actually voted on.rdh/rds— Received by the other chamber.eah/eas— Engrossed Amendment. The other chamber passed an amended version.ath/ats— Agreed to. Both chambers settled on the same text.enr— Enrolled. Final reconciled text, sent to the President.pl— Public Law. Signed by the President. It's now law.pp— Public Print. Official printing post-enactment.
Most bills die before eh/es. Going from pcs → enr is the full path through both chambers.
Line-level diff between text versions of this bill — what actually changed at each legislative stage.
+143
−51
27 unchanged
--- Introduced (Senate)
+++ Reported (Senate)
@@ -1,10 +1,11 @@
[From the U.S. Government Publishing Office]
-[S. 1157 Introduced in Senate (IS)]
+[S. 1157 Reported in Senate (RS)]
<DOC>
+Calendar No. 308
119th CONGRESS
-1st Session
+2d Session
S. 1157
To direct the Secretary of Health and Human Services to conduct a
@@ -17,9 +18,15 @@
March 26, 2025
-Ms. Smith (for herself and Mrs. Capito) introduced the following bill;
-which was read twice and referred to the Committee on Health,
-Education, Labor, and Pensions
+Ms. Smith (for herself, Mrs. Capito, Ms. Hirono, and Ms. Collins)
+introduced the following bill; which was read twice and referred to the
+Committee on Health, Education, Labor, and Pensions
+
+January 28, 2026
+
+Reported by Mr. Cassidy, with an amendment
+[Strike out all after the enacting clause and insert the part printed
+in italic]
_______________________________________________________________________
@@ -32,59 +39,144 @@
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
+<DELETED>SECTION 1. SHORT TITLE.</DELETED>
+
+<DELETED> This Act may be cited as the ``Women and Lung Cancer
+Research and Preventive Services Act of 2025''.</DELETED>
+
+<DELETED>SEC. 2. INTERAGENCY REVIEW TO EVALUATE AND IDENTIFY
+OPPORTUNITIES FOR THE ACCELERATION OF RESEARCH ON LUNG
+CANCER IN WOMEN AND UNDERSERVED POPULATIONS, GREATER
+ACCESS TO PREVENTIVE SERVICES, AND STRATEGIC PUBLIC
+AWARENESS AND EDUCATION CAMPAIGNS.</DELETED>
+
+<DELETED> (a) In General.--The Secretary of Health and Human
+Services, in consultation with the Secretary of Defense and Secretary
+of Veterans Affairs, shall conduct an interagency review to evaluate
+the status of, and identify opportunities for the acceleration of
+research related to--</DELETED>
+<DELETED> (1) research on lung cancer in women;</DELETED>
+<DELETED> (2) research on lung cancer in underserved
+populations that meet the eligibility criteria for lung cancer
+screening as recommended by the United States Preventive
+Services Task Force;</DELETED>
+<DELETED> (3) access to lung cancer preventive services;
+and</DELETED>
+<DELETED> (4) strategic public awareness and education
+campaigns on lung cancer.</DELETED>
+<DELETED> (b) Content.--The review and recommendations under
+subsection (a) shall include--</DELETED>
+<DELETED> (1) a review and comprehensive report on the
+outcomes of previous research, the status of existing research
+activities, and knowledge gaps related to lung cancer in women
+and underserved populations in all agencies of the Federal
+Government;</DELETED>
+<DELETED> (2) opportunities for collaborative, interagency,
+multidisciplinary, and innovative research, that would--
+</DELETED>
+<DELETED> (A) encourage innovative approaches to
+eliminate knowledge gaps in research on lung cancer in
+women;</DELETED>
+<DELETED> (B) evaluate environmental and genomic
+factors that may be related to the etiology of lung
+cancer in women; and</DELETED>
+<DELETED> (C) foster advances in imaging technology
+and techniques to improve risk assessment, diagnosis,
+treatment, and the simultaneous utilization of other
+preventive services and activities;</DELETED>
+<DELETED> (3) opportunities regarding the development of a
+national lung cancer screening strategy to expand access to
+such screenings, particularly among women and underserved
+populations; and</DELETED>
+<DELETED> (4) opportunities regarding the development of a
+national public education and awareness campaign on--</DELETED>
+<DELETED> (A) lung cancer in women and underserved
+populations; and</DELETED>
+<DELETED> (B) the importance of early detection of
+lung cancer.</DELETED>
+<DELETED> (c) Report.--Not later than 2 years after the date of the
+enactment of this Act, the Secretary of Health and Human Services shall
+submit to Congress a report on the review conducted under subsection
+(a).</DELETED>
+
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Women and Lung Cancer Research and
Preventive Services Act of 2025''.
-SEC. 2. INTERAGENCY REVIEW TO EVALUATE AND IDENTIFY OPPORTUNITIES FOR
-THE ACCELERATION OF RESEARCH ON LUNG CANCER IN WOMEN AND
-UNDERSERVED POPULATIONS, GREATER ACCESS TO PREVENTIVE
-SERVICES, AND STRATEGIC PUBLIC AWARENESS AND EDUCATION
-CAMPAIGNS.
+SEC. 2. INTERAGENCY REVIEW TO EVALUATE AND IDENTIFY OPPORTUNITIES TO
+IMPROVE LUNG CANCER PREVENTION AND TREATMENT IN WOMEN.
(a) In General.--The Secretary of Health and Human Services, in
-consultation with the Secretary of Defense and Secretary of Veterans
-Affairs, shall conduct an interagency review to evaluate the status of,
-and identify opportunities for the acceleration of research related
-to--
-(1) research on lung cancer in women;
-(2) research on lung cancer in underserved populations that
-meet the eligibility criteria for lung cancer screening as
-recommended by the United States Preventive Services Task
-Force;
-(3) access to lung cancer preventive services; and
-(4) strategic public awareness and education campaigns on
-lung cancer.
-(b) Content.--The review and recommendations under subsection (a)
-shall include--
-(1) a review and comprehensive report on the outcomes of
-previous research, the status of existing research activities,
-and knowledge gaps related to lung cancer in women and
-underserved populations in all agencies of the Federal
-Government;
-(2) opportunities for collaborative, interagency,
-multidisciplinary, and innovative research, that would--
-(A) encourage innovative approaches to eliminate
-knowledge gaps in research on lung cancer in women;
-(B) evaluate environmental and genomic factors that
-may be related to the etiology of lung cancer in women;
+consultation with the Secretary of Defense and the Secretary of
+Veterans Affairs, shall review and, as necessary and appropriate,
+update Federal programs, activities, and strategic plans related to
+lung cancer research, prevention, diagnosis, and treatment for purposes
+of--
+(1) identifying and addressing knowledge gaps and improving
+health outcomes related to lung cancer in women and populations
+with few known risk factors; and
+(2) improving lung cancer screening rates among populations
+recommended by the United States Preventive Services Task Force
+to receive such screening.
+(b) Content.--The review under subsection (a) shall include--
+(1) a review of findings from research on lung cancer in
+populations described in paragraphs (1) and (2) of subsection
+(a), the status of ongoing federally funded research on lung
+cancer in such populations, and knowledge gaps related to lung
+cancer in such populations;
+(2) consideration of additional research opportunities,
+including through interagency collaboration and
+multidisciplinary projects, that would--
+(A) eliminate knowledge gaps in research on lung
+cancer in women, including an evaluation of any
+environmental and genomic factors that may be related
+to the etiology of lung cancer in women;
+(B) improve screening rates among populations
+described in subsection (a)(2); or
+(C) foster advances in technology and
+interventions, including biomarker testing, to improve
+lung cancer risk assessment, diagnosis, and treatment;
and
-(C) foster advances in imaging technology and
-techniques to improve risk assessment, diagnosis,
-treatment, and the simultaneous utilization of other
-preventive services and activities;
-(3) opportunities regarding the development of a national
-lung cancer screening strategy to expand access to such
-screenings, particularly among women and underserved
-populations; and
-(4) opportunities regarding the development of a national
-public education and awareness campaign on--
-(A) lung cancer in women and underserved
-populations; and
-(B) the importance of early detection of lung
-cancer.
+(3) a review of current public health strategies, and
+consideration of alternative evidence-based strategies, related
+to lung cancer screening and diagnosis, including an assessment
+of the need for additional public awareness and education.
(c) Report.--Not later than 2 years after the date of the enactment
of this Act, the Secretary of Health and Human Services shall submit to
-Congress a report on the review conducted under subsection (a).
-<all>
+the Committee on Health, Education, Labor, and Pensions and the
+Committee on Appropriations of the Senate and the Committee on Energy
+and Commerce and the Committee on Appropriations of the House of
+Representatives a report on the review conducted under subsection (a),
+including--
+(1) a summary of research findings, ongoing research
+projects, and knowledge gaps described in subsection (b)(1);
+(2) a description of any changes made by such Secretary or
+the head of any other Federal agency to Federal programs,
+activities, or strategic plans based on the findings of the
+review; and
+(3) any additional changes to Federal programs, activities,
+or strategic plans recommended by the Secretary based on the
+review, and any statutory or other barriers that impede
+implementation of such changes.
+Calendar No. 308
+
+119th CONGRESS
+
+2d Session
+
+S. 1157
+
+_______________________________________________________________________
+
+A BILL
+
+To direct the Secretary of Health and Human Services to conduct a
+review to evaluate the status of research on lung cancer in women and
+underserved populations, and for other purposes.
+
+_______________________________________________________________________
+
+January 28, 2026
+
+Reported with an amendment
Lobbying activity
Organizations whose LDA filings reference this bill, ranked by filing count. Position not disclosed — LDA does not require lobbyists to report support / oppose / monitor. Bill-number references can be stale (lobbyists sometimes copy text year-over-year), so verify against the filing description.
5
filings · 2026 Q3
5
filings · 2026 Q3
1
filings · 2026 Q1
via Senate LDA · self-reported quarterly. Filing count = filings mentioning this bill (no position required), not money spent on it. Click a client to see all bills they've filed on.
Cosponsors (3)
Members who signed on to support this bill.